Aspire Biopharma Holdings, Inc. (ASBP)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 26, 2025 | CORRESP | Neutral/Informational | Moderate | Aspire Biopharma Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for it to be decl… | Read Filing EDGAR |
| Sep. 24, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Aspire Biopharma Holdings, Inc. that it will not review their registration statement filed on September 18, 2025. The letter emphasizes the company's r… | Read Filing EDGAR |
| May. 28, 2025 | CORRESP | Neutral/Informational | Moderate | Aspire Biopharma Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for it to be decl… | Read Filing EDGAR |
| May. 20, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Aspire Biopharma Holdings, Inc. that it will not review their registration statement filed on May 13, 2025. The letter emphasizes the company's respons… | Read Filing EDGAR |
| Apr. 18, 2025 | CORRESP | Neutral/Informational | Moderate | Aspire Biopharma Holdings, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for it to be decl… | Read Filing EDGAR |
| Apr. 16, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Aspire Biopharma Holdings, Inc. that they will not be reviewing the company's registration statement filed on April 9, 2025. The SEC has reminded the c… | Read Filing EDGAR |